世界中医药
文章摘要
引用本文:赵兰风1,马洪举2,林国华1,徐振华3.腧穴热敏灸治疗哮喘慢性持续期的临床观察[J].世界中医药,2019,(08):.  
腧穴热敏灸治疗哮喘慢性持续期的临床观察
Clinical Observation on Acupoint Heat-Sensitive Moxibustion in the Treatment of Chronic Persistent Asthma
投稿时间:2019-04-16  
DOI:10.3969/j.issn.1673-7202.2019.08.046
中文关键词:  哮喘  慢性持续期  腧穴热敏灸  肺通气功能  临床疗效
English Keywords:Asthma  Chronic persistent stage  Acpoint heat-sensitive moxibustion  Pulmonary ventilation function  Clinical research
基金项目:“十一·五”国家科技支撑计划项目(2006BAI12B04-2)
作者单位
赵兰风1,马洪举2,林国华1,徐振华3 1 广州中医药大学第一附属医院,广州,510405
2 广东省第二中医院,广州,510095
3 广东省中医院,广州,510530 
摘要点击次数: 692
全文下载次数: 514
中文摘要:
      目的:比较腧穴热敏灸和西药舒利迭治疗哮喘慢性持续期的差异。方法:选取2011年5月至2012年11月广州中医药大学第一附属医院和广东省第二中医院收治的符合标准的哮喘慢性持续期患者30例作为研究对象,按照随机数字表法分为观察组和对照组,每组15例。观察组采用足太阳膀胱经的肺俞穴和膈俞穴之间施行温和悬灸。疗程:隔日治疗1次,1个月为1个疗程,治疗3个疗程。对照组采用舒利迭,1吸/次,2次/d,1个月为1个疗程,治疗3个疗程。比较2组患者肺通气功能,临床症状单项评分及总分评定和临床疗效。2组患者均于于治疗前、治疗第30天、治疗第60天观察。结果:2组患者肺通气功能比较:2组患者治疗后3个月、治疗后6个月的肺通气功能(PEF、FEV1)均较治疗前有所提高,治疗前后比较差异有统计学意义(均P<005);且治疗后3个月、治疗后6个月观察组较对照组提高的更加明显(均P<005)。临床症状评分比较:治疗后3个月、治疗后6个月,2组患者症状单项评分和症状总分评分较治疗前均有上升,比较有统计学意义(均P<005);且治疗后3个月、治疗后6个月观察组较对照组临床症状评分提高的更加明显(均P<005),说明腧穴热敏和西药对哮喘慢性持续期均有改善的作用,观察组优于对照组。2组患者临床疗效比较:观察组有效率为800%,对照组为533%,2组患者总有效率比较,差异有统计学意义(P<005)。结论:腧穴热敏灸治疗哮喘慢性持续期在改善肺通气功能、临床症状观察评分、临床疗效判定方面均优于西药舒利迭,值得临床推广。
English Summary:
      To compare the difference between acupoints heat-sensitive moxibustion and Seretide in treating chronic persistent asthma.Methods:A total of 30 cases of chronic persistent asthma patients in The First Affiliated Hospital of Guangzhou University of Chinese Medicine from May 2011 to November 2012 were selected and randomly divided into an observation group and a control group according to random number table,with 15 cases in each group.The observation group was given suspended moxibustion at Feishu(BL13)and Geshui(BL17)in bladder meridian of foot greater yang,with one treatment every other day,1 month as one course of treatment,for 3 courses.The control group was given seretide,one inhaled every time,twice a day,1 month as one course of treatment,for 3 courses.The pulmonary ventilation function,clinical symptoms single score and total score evaluation and clinical efficacy of the 2 groups were compared before treatment,30 days and 60 days after treatment.Results:Comparison of pulmonary ventilation function between the 2 groups:The pulmonary ventilation function(PEF,FEV1)of the 2 groups was improved after 3 months and 6 months of treatment compared with that before treatment,and there was a significant difference before and after treatment(all P<005).The improvement of the observation group was more obvious than that of the control group 3 months after treatment and 6 months after treatment(all P<005).Comparison of clinical symptom score:after 3 months and 6 months of treatment,the single symptom score and total symptom score of the 2 groups increased compared with those before treatment,with statistical significance(all P<005).The scores of clinical symptoms in the observation group were significantly higher than those in the control group after 3 months and 6 months of treatment(all P<005),which indicated that acupoint heat-sensitive moxibustion and western medicine had improved the chronic persistence of asthma,and the observation group was better than the control group.Comparison of clinical efficacy between 2 groups:the effective rate of the observation group was 800%,and that of the control group was 533%.There was significant difference in the total effective rate between the 2 groups(P<005).Conclusion:The acupoint heat-sensitive moxibustion in the treatment of chronic persistent asthma was superior to western medicine Seretide in improving pulmonary ventilation function,clinical symptoms observation score and clinical efficacy judgment,which is worthy of clinical promotion.
查看全文  查看/发表评论  下载PDF阅读器